Anticandidal Agents
- Publisher's listprice EUR 64.95
-
27 551 Ft (26 239 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 2 755 Ft off)
- Discounted price 24 796 Ft (23 615 Ft + 5% VAT)
27 551 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Academic Press
- Date of Publication 16 September 2016
- ISBN 9780128113110
- Binding Paperback
- No. of pages94 pages
- Size 228x152 mm
- Weight 160 g
- Language English 0
Categories
Long description:
Anticandidal Agents provides the latest information on candida drug resistance and its remedial implications. In this compilation, users will find a comprehensive view on overcoming resistance in anticandidal drugs, along with information on novel molecules.
Candida albicans is an opportunistic pathogenic fungus responsible for life threating invasive and nosocomial infections across the globe. Candidiasis is a major cause of morbidity among immunocompromised patients. Infections caused by non-albicans candida like C. glabrata, C. parapsilosis, and C. tropicalis have also imposed a serious threat in the last few decades. Current treatment of candidiasis relies primarily on antifungal agents broadly categorized as azoles, polyenes, echinocandins, allylamines, and pyrimidines.
Lately, antifungal resistance has emerged to be an obstruction of current treatment regime. A number of reasons are described in detail. Understanding the mechanisms of resistance is crucial for developing strategies for overcoming the hindrance in current therapeutics.
MoreTable of Contents:
Chapter 1. Introduction
Chapter 2. Host-Pathogen Interaction
Chapter 3. Antifungals Used Against Candidiasis
Chapter 4. Drug Resistance in Candida
Chapter 5. Multidrug Resistance and Transporters
Chapter 6. Potential Anticandidal Targets
Chapter 7. Drug Development Strategies
Chapter 8. Conclusion
More
